-transparent.png){kind=logo}
Phenol sulfotransferase (PST) catalyzes the sulfate conjugation of many phenolic drugs. Human liver contains thermostable (TS) and thermolabile forms of PST. Ion exchange chromatography shows that two isozymes of TS PST (peaks I and II) are present in human liver preparations. Rat liver contains four forms of PST that can be separated by ion exchange chromatography. Quantitative structure-activity relationship (QSAR) analysis was used to study phenolic substrates for both human and rat liver PST. Thirty-six substituted phenols were tested as substrates for partially purified human liver TS PST peak I. QSAR analysis resulted in derivation of the following equation: log 1/Km = 0.92 (+/- 0.18)log P - 1.48 (+/- 0.38)MR'4 - 0.64 (+/- 0.41)MR3 + 1.04 (+/- 0.63)MR2 + 0.67(+/- 0.44) sigma- + 4.03 (+/- 0.42). In this equation Km is the Michaelis constant, P is the octanol-water partition coefficient, MR is the molar refractivity of substituents at the 2-, 3-, and 4-positions, and sigma- is the Hammett constant. Values of log 1/Km calculated with this equation were highly correlated with log 1/Km values (r = 0.950) that were observed experimentally. Nine phenols were also tested as substrates for partially purified human liver TS PST peak II. Log 1/Km values for these compounds were significantly correlated for the two isozymes of TS PST (r = 0.992, p less than 0.001). QSAR analysis was also used to derive equations that described the behavior of phenolic substrates for rat liver PST forms I and II. These equations differed substantially from the equation derived for compounds tested with human liver TS PST peak I. Therefore, the characteristics of the active sites of human liver TS PST peak I and rat liver PST forms I and II appear to differ. Application of these equations may make it possible to predict Km values of phenolic substrates for human liver TS PST and for rat liver PST forms I and II.
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
February 1991,
Xenobiotica; the fate of foreign compounds in biological systems,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
May 1990,
Archives of biochemistry and biophysics,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
March 1995,
Biochemical pharmacology,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
January 1992,
Drug metabolism and disposition: the biological fate of chemicals,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
April 1982,
The Journal of pharmacology and experimental therapeutics,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
January 1991,
Drug metabolism and disposition: the biological fate of chemicals,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
February 1995,
Thyroid : official journal of the American Thyroid Association,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
September 1990,
Biochemical pharmacology,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
October 1996,
Pharmaceutical research,
N R Campbell, and
J A Van Loon, and
R S Sundaram, and
M M Ames, and
C Hansch, and
R Weinshilboum
May 1975,
Biochemical pharmacology,
